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The frequency of HLA-B27 in patients with Ankylosing Spondylitis (AS) is over 85%.
There are more than 170 recognized HLA-B27 alleles but the majority of them is not
sufficiently represented for genetic association studies. So far only two alleles, the
HLA-B∗2706 in Asia and the HLA-B∗2709 in Sardinia, have not been found to be
associated with AS. The highly homogenous genetic structure of the Sardinian population
has favored the search of relevant variants for disease-association studies. Moreover,
malaria, once endemic in the island, has been shown to have contributed to shape
the native population genome affecting the relative allele frequency of relevant genes. In
Sardinia, the prevalence of HLA-B∗2709, which differs from the strongly AS-associated
B∗2705 prototype for one amino acid (His/Asp116) in the F pocket of the peptide binding
groove, is around 20% of all HLA-B27 alleles. We have previously hypothesized that
malaria could have contributed to the establishment of this allele in Sardinia. Based
on our recent findings, in this perspective article we speculate that the Endoplasmic
Reticulum Amino Peptidases, ERAP1 and 2, associated with AS and involved in antigen
presentation, underwent co-selection by malaria. These genes, besides shaping the
immunopeptidome of HLA-class I molecules, have other biological functions that could
also be involved in the immunosurveillance against malaria.
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INTRODUCTION
HLA-B27 and Ankylosing Spondylitis (AS) is a paradigmatic example of association between the
HLA and an immuno-mediated disease (1, 2). Yet, the molecular basis of this association remains
unclear. There are several reasons for this failure: the complex genetics of the disease that lacks
conclusive animal models; the site of lesions, the enthesis, hard to explore, as well as the lack of
specific markers of inflammation (3–5). It has been shown that inflammatory bowel diseases (IBD)
and AS frequently co-occur with 5–10% of AS cases having clinical IBD and approximately 70%
having subclinical bowel inflammation (6, 7). Moreover, there is a genetic overlap between the
two diseases, although HLA-B27 remains a hallmark of AS and its role, although still undisclosed,
appears to be prevalent and specific (8, 9).
With the advances in the molecular techniques, more than 170 recognized HLA-B27 alleles
(http://www.ebi.ac.uk/cgi-bin/ipd/imgt/hla/allele.cgi) have been identified. However, the majority
of them is not sufficiently represented to enable association studies (10). So far only two alleles,
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the HLA-B∗2706 in Asia and the HLA-B∗2709 in Sardinia, have
been shown to be absent or rarely present in patients with AS (11–
13). Structural and functional differences distinguish the B∗2706
and B∗2709 alleles from their closest pair, the B∗2704 and B∗2705,
respectively (11, 14). Dissecting such differences can therefore
give a clue to the molecular basis of this impressive association.
THE HLA-B∗2709: A SARDINIAN ALLELE
WITH A NEUTRAL EFFECT ON AS
The tale of the HLA-B∗2709 has its origin from studies aimed
to characterize, at subtyping level, the HLA-B27-restriction of
autoreactive, cytotoxic γδ T cells (15). Surprisingly, these cells
killed B-LCLs from HLA-B27 positive members of the proband
family but not unrelated HLA-B∗2705 positive B-LCLs. cDNA
sequencing disclosed a single amino acid variance in the binding
groove of the HLA-B27 molecules (Asp/His 116) that made
highly specific this recognition. Noteworthy, this novel allele,
named B∗2709, was frequent enough to enable association
studies in Continental Italy. Most interesting, this allele showed
the highest frequency in Sardinia, a Mediterranean island of
about 1.6 × 106 inhabitants, where it represents 20% of all
HLA-B27 subtypes (13). So far, we have analyzed a total of
50 HLA-B∗2709-positive subjects from Sardinia and only one
was affected by AS. However, this patient carried also another
AS-risk allele, the B∗1403 (16). Therefore, to the best of our
knowledge, at least in Sardinia the B∗2709 allele does not
confer susceptibility to AS. Although the B∗2709 is harbored
by a different HLA haplotype compared to the B∗2705, there
is little evidence supporting this as an explanation for this lack
of association (17, 18). Moreover, the observation that another
allele, the B∗2706, more frequent in Asia and differing from
the common B∗2704 for two amino acids Asp/His 114 and
Tyr/Asp 116 (11), both located in the peptide binding groove,
gave strength to the hypothesis of the “arthritogenic” peptide/s
(19). This predicts the existence of a specific HLA-B27-restricted
“self immunopeptidome” triggering autoreactive CTLs primarily
elicited by cross-reactive microbial peptides. This opened a
research vein pointing to analyse the immunopeptidomes eluted
from HLA-B27 molecules associated or non-associated with
the disease (20). Indeed, although in the course of several
decades many structural and functional differences could be
observed, nevertheless no clear-cut indications came out from
these studies and other scientifically substantiated hypotheses
have been proposed (14, 21–23). More recently, a report has
singled out 26 peptides preferentially eluted from the HLA-B27
associated alleles, giving a new ground to search for candidate
peptides possibly involved in disease pathogenesis (24).
ERAP1 AND ERAP2 CONTRIBUTE TO AS
SUSCEPTIBILITY
A strong support to the theory that antigen presentation
contributes to the disease, came from the finding that the ER-
resident aminopeptidases, ERAP1 and ERAP2 showed also an
association with AS and other “MHC-I-opathies” (25–29). These
intracellular enzymes are pivotal to the generation of 8–10
mer peptides that serve as ligands for HLA-class I molecules
by trimming longer (ERAP1) or shorter (ERAP2) peptides as
discussed in depth by Lopez de Castro in this same Research
Topic (30). However, while ERAP1 appears to act in epistasis
with the predisposing HLA-class I molecules, ERAP2 does not
(26, 31). Indeed, ERAP2 has been found to confer susceptibility
also to other diseases for which a stringent association with HLA-
class I has not been established, as in the case of Crohn’s Disease.
This suggests a role for ERAP2 by mechanisms which go beyond
the peptidome shaping.
HLA REGION UNDERGOES POSITIVE
SELECTION
HLA-class I genes fulfill a crucial role in the defense against
intracellular invaders: the more efficient they are, the more
likely is the surviving of the species. Therefore, infectious agents
represent one of the most powerful selective pressure impacting
on the human genome in general and, specifically, on the HLA
genes (32, 33). This can generate the potential for disorders that
involve phenotype alterations such as, in the case of HLA region,
autoimmune diseases. The question whether the risk alleles have
undergone positive selection has been highly debated. There
are however, molecular genetic data that strongly support this
hypothesis (33–38). An example of a locus that appears to have
been subject to strong positive selection is the HLA 8.1 ancestral
haplotype, a conserved combination of HLA genes present in
15% of Caucasians, that plays a key role in the inflammatory
response and protects from infectious diseases. As a counterpart,
its presence is associated with an increased risk toward several
autoimmune disorders (39, 40).
In this context, HLA-B27 positive subjects appear to display
a more effective immunosurveillance against some viruses such
as HIV, hepatitis C and EBV either because able to present
relevant epitopes and/or by contributing to the inflammatory
microenvironment needed for an effective response to occur
(14). As in the case of HLA 8.1 haplotype, the HLA-
B27 could confer as trade off, a higher predisposition to
autoimmune/autoinflammatory diseases such as AS.
THE CASE OF HLA-B27
Although a high number of HLA-B27 alleles have been described,
only for few of them a worldwide distribution and a functional
impact has been documented: i.e. the ancestral and strongly AS-
associated B∗2705, the B∗2702 and B∗2707 more frequent in the
Middle East, the B∗2704 and B∗2706 in the East, the B∗2703 in
Africa and the B∗2709 in Sardinia (11, 14).
Most interestingly, there is a descending gradient from north
to south of the HLA-B27 allelic distribution. In particular, the
ancestral HLA-B∗2705 covers a wide spectrum of frequencies:
from more than 20% in North Europe to <1% in the sub-
Saharan Africa (41, 42). Of note, the distribution of the above
mentioned non-B∗2705 subtypes follows an opposite gradient
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which is superimposable to that of malaria: more frequent in the
area in which malaria was endemic and lower in North Europe.
These observations lead us to postulate that HLA-B∗2705
allele could have been counter-selected by malaria and that the
establishment of the different subtypes has been favored by this
environmental pressure (42).
However, negative selection is very difficult to prove. A hint to
this theory could come from the analysis of the allelic distribution
of other genes, also participating in the shaping of the HLA-B27
peptidome.
DID THE AMINOPEPTIDASES UNDERGO
SELECTION BY MALARIA? SUGGESTIVE
OBSERVATIONS
The aminopeptidases ERAP1, ERAP2, and LNPEP (Leucyl-
cystinyl aminopeptidase) are intracellular enzymes encoded by
polymorphic genes contiguously located on chromosome 5q15.
Some of these polymorphisms are functional and have been
found associated with AS. In the case of ERAP1, the missense
SNP rs30187 has been functionally related to the level of
trimming activity and, notably, the allelic variant associated
with AS shows a more efficient ERAP1 enzymatic activity (26).
ERAP2, that associates with AS in its HLA-B27-negative forms
as well (31), shows two main haplotypes in strong Linkage
Disequilibrium (LD), HapA and HapB, the latter not expressing
ERAP2 due to the balanced polymorphism at SNP rs2248374
that impacts on RNA stability. Therefore, 25% of the population
is ERAP2 negative (43). It has been recently proposed that this
balanced strong LD might be due to the role that ERAP2 can
play in the immune evasion of trophoblasts (44). The analysis of
its distribution in AS patients and healthy subjects has indicated
that the absence of ERAP2 is protective for AS as well as
for other inflammatory diseases, although the reasons for this
protection are far from being elucidated (31, 45). Interestingly,
the full expression of ERAP2 as observed in HapA homozygous
individuals, appears to play a role in protecting from HIV
infection, most probably modulating antigen presentation (46).
This is a further indication that autoimmunity can be the
downside of an effective immune response. In this context, a
recent report has indicated CD8+ T cells as key players in the
development of cerebral malaria, a life-threatening complication
of the P. falciparum infection. These T cells have a two-
faced role: in the parasite clearance from blood and liver
and in the induction of neuroinflammation. This is apparently
due to CCDC88B, a risk locus for several auto-inflammatory
conditions among which IBD and psoriasis, both of which
showing a genetic overlap with AS (47). Although this gene has
not been found associated with AS, nevertheless other genes
TABLE 1 | Allele frequencies of C, G, G, and A variants at rs30187, rs75862629, rs2248374, and rs2303138 respectively, in the populations analyzed in the 1,000
Genomes Project.
Population Allelic frequency (%)
rs30187 rs75862629 rs2248374 rs2303138
C G G A
(YRI) Yoruba in Ibadan, Nigeria 58.3 14.8 60.2 5
(LWK) Luhya in Webuye, Kenya 60.1 13.2 41.9 1.5
(GWD) Gambian in Western Gambia 57.5 13.7 67.3 8.8
(MSL) Mende in Sierra Leone 62.4 9.4 64.1 5.3
(ESN) Esan in Nigeria 64.1 13.1 61.6 6.1
(MXL) Mexican Ancestry from Los Angeles, USA 60.9 11.7 52.3 2.3
(PUR) Puerto Ricans from Puerto Rico 57.2 10.1 57.2 7.7
(PEL) Peruvians from Lima, Peru 67.1 13.5 63.5 2.1
(CHB) Han Chinese in Beijing, China 50.5 1 62.1 44.7
(JPT) Japanese in Tokyo, Japan 54.8 0.5 48.6 36.1
(CHS) Southern Han Chinese 51.4 0 57.6 44.3
(CDX) Chinese Dai in Xishuangbanna, China 57 0 47.9 39.3
(KHV) Kinh in Ho Chi Minh City, Vietnam 60.1 0 43.9 33.3
(FIN) Finnish in Finland 68.7 6.6 54.5 7.6
(GBR) British in England and Scotland 63.6 7.7 44 5.5
(IBS) Iberian population in Spain 62.6 9.4 53.7 7.5
(TSI) Toscani in Italy 62.6 13.5 56.5 4.7
Pakistan(PJL) Punjabi from Lahore, Pakistan 60.4 4.2 60.4 16.2
(GIH) Gujarati Indian from Houston, Texas 54.8 7.8 58.7 19.9
(BEB) Bengali from Bangladesh 57 3.5 51.7 20.3
(STU) Sri Lankan Tamil from the UK 63.2 3.5 49.5 18.6
(ITU) Indian Telugu from the UK 59.8 9.8 43.6 10.8
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FIGURE 1 | Climate plan-sphere and the world allelic frequencies (https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/) of the ERAP rs30187C variant
(bottom left), or of the ERAP2 rs75862629G (top right) and rs2248374G (bottom right). The black and purple boxes indicate, respectively, the regions where HbS and
HbC hemoglobin variants are more frequent.
involved in the CD8+ T cells differentiation and activity do
have (26).
More recently, other ERAP2 functional polymorphisms have
been described. In particular, our group has shown that the
minor allele G at SNP rs75862629 in the promoter region of
ERAP2 couples a lower expression of ERAP2 with a higher
expression of ERAP1 (48). Interestingly, this finding reveals for
the first time that the transcription of the two genes is interlinked.
There are several possible explanations for this observation: i.e. a
direct competition of the two genes for the same transcription
factor/s or a steric hindrance or even an indirect effect due
to intermediates. Since the worldwide frequency of this minor
allele ranges between 5 and 15%, it will be most important to
test its association with the “MHC-I-opathies,” in the different
populations.
Here, we have analyzed the worldwide distribution of some
SNPs in the aminopeptidase genes. In particular, we report
the frequencies derived from the 1,000 genomes (https://
www.ncbi.nlm.nih.gov/variation/tools/1000genomes/) of the
missense rs30187 in the ERAP1 coding region, as well as the
distribution of rs2248374 and rs75862629 in the ERAP2 gene
(Table 1; Figure 1). Although the data are based only on some
ethnic groups, we noticed an interesting distribution of the
ERAP2 polymorphisms: the G alleles at both rs75862629
and rs2248374, which co-segregate respectively, with a
lower or null expression of ERAP2, were more frequent in
the equatorial regions. This is reminiscent of the malaria
distribution as well as of the occurrence of the HLA-B27
subtypes.
In Sardinia, the malaria has been endemic since the old
age up until the ’50s and has favored the establishment of
genetic variants more efficient in fighting the adverse effects
of Plasmodium infection (49). This was not without a price
and a higher presence of diseases such as thalassemia or
G6PD deficiency is a common trait in Sardinia (50). More
recently, a robust evidence in the selection of variants conferring
susceptibility to some autoimmune diseases has also been
provided (51, 52).
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As for ERAP2, the frequency in Sardinia of the rs75862629
MAF is among the highest (about 14%). These observations seem
to suggest that ERAP2 could have been a target of selection and,
more precisely, those alleles determining a lower expression of
ERAP2 appear to be favored in the areas where the P. falciparum
has been endemic. Is this because a lower expression of ERAP2
confers some protection from the most severe form of malaria?
There are some observations that could give support to
this speculation: (1) the co-segregation with HLA-B27 subtypes
whose occurrence has been already proposed as consequence of
a selection by P. falciparum (49); (2) the multifaceted nature
of this enzyme: ERAP2, besides being involved in antigen
presentation, has a role in the regulation of blood pressure
as well. Interestingly, a lower activity of ERAP2 has been
correlated with a basal diastolic higher pressure (53), whose
implication as a protective factor against malaria is becoming
an increasingly accredited hypothesis. In this context, a lower
expression of ERAP2 has been found in the first trimester of
pregnancy in women that will develop pre-eclampsia (PE), a
disease that is the main cause of maternal and fetal morbidity
and has a strong genetic background (54). Recent studies in
Australian/NewZealand andNorwegian populations have shown
that one of the two possible ERAP2 haplotypes is associated
with PE susceptibility (55). The same variations have been
also associated with increased risk of hypertensive disorders in
pregnancy in African American population (56) but not in the
Chilean population. Of note, this population has also a different
distribution of the ERAP2 SNPs which are not in complete LD as
in the other populations (57).
It is therefore conceivable that malaria is the factor that has
favored the establishment of polymorphisms correlating with
a lower expression of ERAP2. The allele G at rs2248374 that
determines the ERAP2 mRNA non-sense mediated decay, has
a frequency higher than 60% in the equatorial Africa and,
remarkably, the minor allele at rs75862629, also correlating with
a lower ERAP2 transcription, reaches its highest frequency in the
same regions (Table 1; Figure 1). In this context, it is interesting
to note that the worldwide distribution of abnormal variants of
hemoglobin (HbS, HbC) selected by malaria (58) shows a good
overlap with that of G variant at rs75862629 (Figure 1). This
supports the hypothesis that hypertension, in particular when co-
occurring with erythrocyte variations that reduce Plasmodium
proliferation, can play a protective role against Plasmodium
infection.
Of note, in East Asia, where the frequency of AS is much lower
than in the western hemisphere (59), haplotype combinations
in the region where ERAP1, ERAP2, and LNPEP map, are
different with a prevalence of ERAP2 variants that favor protein
expression. To which extent this might be due to genetic
drift, ERAP2 selection, or variants in LD with ERAP2, it
remains to be established. It is suggestive, however, that in
Asia, P. vivax rather than P. falciparum, is the main cause
of malaria (60). This observation also might suggest that,
where ERAP1/ERAP2/LNPEP genomic region has undergone a
selective pressure from malaria, it may even have operated at
both systemic and immunological level. In fact, like ERAP1 and
ERAP2, LNPEP regulates the renin–angiotensin system and is
involved in peptide trimming, as well (61). In addition, LNPEP
is able to activate the NF-κB pathway (62). Noteworthy, in
Asia, where ERAP2 displays a minor degree of polymorphism,
LNPEP variants have been described to correlate with the onset
of autoinflammatory phenomena, as well as with susceptibility
to hypertension: i.e., the A variant in LNPEP rs2303138, in East
Asia (40% in Asia, 5–6% in the rest of the world) (Table 1)
is in LD with the productive allele A in ERAP2 rs2248374,
but correlates with a lower expression of LNPEP (63). This, as
consequence, determines in the serum a higher level of its target,
the Angiotensin II, which could limit the erythrocyte invasion by
Plasmodium avoiding the complications of cerebral malaria (64).
CONCLUSIONS
In conclusion, functional variants of the three aminopeptidases
ERAP1, ERAP2, and LNPEP show a worldwide distribution
compatible with a selective pressure by malaria. Some of
these variants co-occur with HLA-B27 subtypes. In particular,
in Sardinia the distribution of the ERAP2 rs75862629 minor
allele correlates with the presence of the HLA-B∗2709 subtype.
It will be interesting to investigate if this pair shows any
functional interaction and if this has any correlation with AS
susceptibility/protection.
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